Masonic Cancer Center, University of Minnesota
Retinoblastoma is cancer of the thin layer of nerve tissue that lines the back of the eye. This layer is called the retina, which is the light-sensitive portion of the eye that forms images. Retinoblastoma may affect one eye (unilateral), both eyes (bilateral), and in very rare cases, the brain (trilateral). Most often it is found in children under 5 years old. Retinoblastoma does not usually spread to nearby tissues or other parts of the body. When treated early, 95 percent of the cases can be treated and vision may be spared.
There are two types of retinoblastoma: hereditary and non-hereditary.
Hereditary retinoblastoma makes up 30 to 40 percent of retinoblastoma cases. It can be found in one or both eyes, and is usually found in younger children. When the disease is found in both eyes, it is always the hereditary form. Because of the genetic basis of this disease, siblings need to be examined by an eye specialist, and the parents should meet with a genetic counselor. A child with hereditary retinoblastoma also is at greater risk for developing other kinds of cancer elsewhere in the body later in life. These children should continue to have medical check-ups even after the disease has been treated. For more information about genetic counseling, see the Familial Cancer Clinic section.
Non-hereditary retinoblastoma affects one eye only, and is generally found in older children. There is a slight chance that these children are at greater risk for developing cancer elsewhere in the body later in life. As a result, they should continue to have medical check-ups even after the disease has been treated.
Parents usually see the first signs and symptoms of retinoblastoma, and this prompts them to seek medical care. They include:
The persistent presence of one or more of these conditions is good cause to immediately get a medical check-up — especially if other family members now have, or have had in the past, vision problems or cancer.
An ophthalmologist (eye doctor) experienced with treating retinoblastoma is the specialist who can diagnose the disease. It is usually done in the hospital by putting the child under general anesthesia so the eye can be thoroughly examined. Among the examination procedures are:
Once the diagnosis of retinoblastoma is made, the cancer must be "staged." This is a way of classifying the cancer according to size and number of tumors. As it is unlikely to have retinoblastoma outside of the eye, most staging systems evaluate the extent of tumor within the affected eye or eyes. Accurate staging can help the ophthalmologist predict the vision of the eye and can help the treatment team determine the most appropriate treatment strategy for a child.
Treatment depends on the size, number and location of the tumors, whether one or both eyes are affected, and the age of the child. Treatment options that attempt to cure the patient and preserve vision include the following:
Chemotherapy: This is the use of drugs to kill cancer cells.
Cryotherapy: This is the use of extreme cold to destroy cancer cells.
Photocoagulation: This is the use of laser light to destroy blood vessels that supply nutrients to the tumor.
Enucleation: Surgery to remove the eye is performed if the tumor is too advanced to be locally controlled with combinations of chemotherapy and other treatment methods.
Radiation therapy: Uses high-energy radiation from x-rays and other sources to kill cancer cells and shrink tumors. It may come from a machine outside the body — external beam radiation — or from a radiation source implanted into the tumor, or near it. This form is called internal radiation therapy, or brachytherapy.
Treatment depends on whether the cancer is in one or both eyes. If the cancer is in one eye, treatment may be one of the following:
If the cancer is in both eyes, treatment may be one of the following:
In this condition, the cancer has spread and extends beyond the eye. It may be confined to the tissues surrounding the eye, or it may have spread to other parts of the body. Treatment may be one of the following:
Recurrent disease means that the cancer has come back (recurred) or progressed (continued to grow) after it has been treated. It may recur in the eye, the tissues around the eye, or elsewhere in the body. Treatment depends on the site and extent of the spread.
The Masonic Cancer Center is a source of innovative new therapies for pediatric cancers, often referred to as Phase 1 or 2 clinical trials. We have compiled detailed information, including eligibility criteria, for some of the advanced therapies available through the Cancer Center.
If you have questions about clinical trials, contact the Masonic Cancer Center's Cancer Information Line.